GART, TGFB1, ITGA2, SLC16A5, SOX9, and MMP7 with differential connectivity across normal and CRC samples along with SP1, SF1, and JUN TFs could be taken into account for future detection and therapeutic targets by experimental investments. This evidence concerns the gene GART and colorectal carcinoma.